Arrowpoint Investment Partners Singapore Pte. Ltd. bought a new position in The Cooper Companies, Inc. (NASDAQ:COO – Free Report) in the 4th quarter, Holdings Channel.com reports. The fund bought 10,434 shares of the medical device company’s stock, valued at approximately $855,000.
Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Root Financial Partners LLC lifted its stake in Cooper Companies by 104.5% during the fourth quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock worth $26,000 after purchasing an additional 162 shares during the last quarter. Bell Investment Advisors Inc increased its stake in Cooper Companies by 106.3% during the third quarter. Bell Investment Advisors Inc now owns 425 shares of the medical device company’s stock valued at $29,000 after purchasing an additional 219 shares during the last quarter. True Wealth Design LLC increased its stake in Cooper Companies by 484.8% during the fourth quarter. True Wealth Design LLC now owns 462 shares of the medical device company’s stock valued at $38,000 after purchasing an additional 383 shares during the last quarter. Cromwell Holdings LLC increased its stake in Cooper Companies by 128.8% during the fourth quarter. Cromwell Holdings LLC now owns 485 shares of the medical device company’s stock valued at $40,000 after purchasing an additional 273 shares during the last quarter. Finally, Board of the Pension Protection Fund bought a new stake in Cooper Companies during the fourth quarter valued at $41,000. Institutional investors own 24.39% of the company’s stock.
More Cooper Companies News
Here are the key news stories impacting Cooper Companies this week:
- Positive Sentiment: Cooper Companies reported fiscal second-quarter EPS of $1.21, beating the $1.10 consensus, while revenue of $1.08 billion also topped estimates and rose 7.9% year over year. Cooper Companies earnings transcript
- Positive Sentiment: The company also reaffirmed growth momentum by posting improved profitability, with net margin of 9.67% and return on equity of 10.34%, which should support investor confidence. Cooper Companies press release
- Neutral Sentiment: Management guided fiscal 2026 EPS to $4.58-$4.66, which is close to the analyst view of $4.62 and suggests the outlook was acceptable, but not a major upside surprise. Cooper Companies stock page
- Neutral Sentiment: Several earnings-preview articles published ahead of the report likely added attention, but the main stock driver today appears to be the actual results and guidance. Yahoo Finance preview
Analyst Ratings Changes
View Our Latest Research Report on COO
Cooper Companies Price Performance
Shares of NASDAQ COO opened at $62.02 on Friday. The Cooper Companies, Inc. has a fifty-two week low of $58.89 and a fifty-two week high of $89.83. The firm’s 50-day simple moving average is $65.17 and its 200 day simple moving average is $74.57. The company has a quick ratio of 0.79, a current ratio of 1.34 and a debt-to-equity ratio of 0.22. The stock has a market cap of $12.10 billion, a P/E ratio of 30.70, a P/E/G ratio of 1.56 and a beta of 0.87.
Cooper Companies (NASDAQ:COO – Get Free Report) last issued its quarterly earnings data on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, beating analysts’ consensus estimates of $1.10 by $0.11. Cooper Companies had a net margin of 9.67% and a return on equity of 10.34%. The business had revenue of $1.08 billion for the quarter, compared to analysts’ expectations of $1.05 billion. During the same period in the previous year, the business earned $0.96 earnings per share. The company’s revenue was up 7.9% on a year-over-year basis. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Equities analysts expect that The Cooper Companies, Inc. will post 4.62 EPS for the current year.
Cooper Companies Profile
Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.
The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.
Recommended Stories
- Five stocks we like better than Cooper Companies
- The Great AI Server Rotation Puts Hewlett Packard Enterprise and Super Micro Computer in Focus
- Generac’s AI Power Pivot Raises a Bigger Question About Data Center Demand
- Medtronic Bottoms, Healthy Rebound Ahead
- GitLab’s Price Recovery Gains Traction—Time to Get On Board?
Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cooper Companies, Inc. (NASDAQ:COO – Free Report).
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.
